相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased antitumor potential of the raloxifene prodrug, raloxifene diphosphate
Yoshinori Okamoto et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Phase III double-blind trial of Arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer
VijayaLaxmi Deshmane et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Selective estrogen receptor modulators for postmenopausal osteoporosis - Current state of development
Luigi Gennari et al.
DRUGS & AGING (2007)
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women
Elizabeth Barrett-Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention - The NSABP study of tamoxifen and raloxifene (STAR) P-2 trial
Stephanie R. Land et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Antiestrogens and the formation of DNA damage in rats: A comparison
Sung Yeon Kim et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of α-hydroxytamoxifen in rat and human livers
SY Kim et al.
DRUG METABOLISM AND DISPOSITION (2005)
Species- and disposition model-dependent metabolism of raloxifene in gut and liver: Role of UGT1A10
EJ Jeong et al.
DRUG METABOLISM AND DISPOSITION (2005)
K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene
T Hachisuga et al.
BRITISH JOURNAL OF CANCER (2005)
Genotoxic mechanism of tamoxifen in developing endometrial cancer
SY Kim et al.
DRUG METABOLISM REVIEWS (2004)
Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents
VC Jordan
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions
VC Jordan
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment study
SR Goldstein et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Characterization of raloxifene glucuronidation in vitro: Contribution of intestinal metabolism to presystemic clearance
DC Kemp et al.
DRUG METABOLISM AND DISPOSITION (2002)
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial
JA Cauley et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen
S Shibutani et al.
CARCINOGENESIS (2000)
Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene
U Hellmann-Blumberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
